Patch Locoa Transdermal | 7 patches/pack

Description

**PRICE IS FOR 1 PACK (7 PATCHES)
1 PACK - 7 PATCHES
1 BOX - 10 PACK
LOCOA® (Esflurbiprofen), patch transdermal, yang dihasilkan bagi membantu pesakit osteoarthritis meredakan kesakitan yang menjejaskan pergerakan dan aktiviti harian mereka.
Osteoarthritis merupakan sejenis penyakit sendi yang kerap dihidapi dan merupakan salah satu penyumbang terbesar dalam kekurangupayaan global. Apabila seseorang diagnose dengan penyakit osteoarthritis, berkemungkinan sakit rasa akan muncul dengan lebih kerap, justerunya langkah-langkah pencegahan awal perlu diambil walaupun tiada penawar bagi penyakit ini, namun kita dapat memperhatikan tahap rawatan telah dipertingkatkan dalam beberapa tahun kebelakangan ini dan manfaat telah diperolehi apabila memulakan rawatan di peringkat awal.
LOCOA® yang dihasilkan di Jepun telah diluluskan sejak 2016 bertujuan memberi pelbagai pilihan kepada pesakit osteoarthritis dalam mengurangkan kesakitan secara lebih efektif.
Penyakit ini kerap dihidapi dalam golongan lelaki sebelum usia 45 tahun dan wanita selepas usia 45 tahun. Antara simptom yang biasa dialami oleh pesakit osteoarthritis termasuk sakit sendi, kekejangan sendi-sendi, bengkak, kehilangan fungsi, perubahan kepada rupa sendi, kekuatan sendi berkurangan, lutut berbunyi atau sakit apabila sekeliling sendi ditekan.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
LOCOA® (Esflurbiprofen), a transdermal patch, developed to help osteoarthritis patients relieve pain that affects their daily movements and activities.
Osteoarthritis is a common joint disease and is one of the largest contributors to global disability. When a person is diagnosed with osteoarthritis, it is likely that pain will appear more often, so early preventive measures should be taken even if there is no cure for the disease, but we can see the level of treatment has improved in recent years and benefits have been gained when starting treatment at an early stage.
LOCOA® produced in Japan has been approved since 2016 aimed at providing a variety of options to osteoarthritis patients in reducing pain more effectively.
The disease is most common in men before the age of 45 and women after the age of 45. Among the common symptoms experienced by osteoarthritis patients include joint pain, joint spasm, swelling, loss of function, changes in joint appearance, decreased joint strength, knee tingling or pain when around the joint is pressed.